Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Anti-cancer vaccine therapy for hematologic malignancies: An evolving era

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade

Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma

Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors

Targeting immune checkpoints in malignant glioma